INSIGHTS
July 15, 2019

A gutsy investment

Digital therapeutics are poised to tackle chronic and acute conditions—including those that often fly under the radar. 70M Americans have a gut disorder—twice the number of those living with diabetes—and the current standard of care is costly and largely ineffective. We’re thrilled to announce our investment in Vivante Health, whose comprehensive solution is changing the digestive health care paradigm. Welcome, Vivante!

Meanwhile, a few notable folks have been shuffling around the industry: a former CVS Health leader joined Rock Health portfolio company Podimetrics, 23andMe’s Chief Scientific Officer left his post, CMMI‘s Director departed from the agency—and Anthem has been hiring Apple employees in an attempt to get more consumer-friendly.

Headlines

Better Health, Gut First: Our Investment In Vivante Health
The first comprehensive digital solution for digestive health Rock Health | (Tweet)

Microsoft And Providence To Build “Hospital Of The Future”
They’ll also be working closely with employers to lower costs CNBC | (Tweet)

FCC’s Connected Care Pilot Gets Green Light
Expanding telemedicine access for low income Americans, vets Modern Healthcare | (Tweet)

23andMe Is Moving Beyond DNA—And Into Apple’s Territory
It wants to aggregate your medical info, lab tests, and more CNBC | (Tweet)

How Accurate Are Fertility Tracking Apps, Anyway?
“‘There have been products that are overpromising and underdelivering’” Politico | (Tweet)

NHS Teams Up With Amazon To Bring Alexa To Patients
Here’s what some Brits have to say The Guardian | (Tweet)

Clover Health Just Launched Its Own Drug Company
Medicare Advantage meets machine learning to develop drugs MobiHealthNews | (Tweet)

Every Data Point Has A Face: Remembering Michael Becker
When talking about studies of patients, think beyond the data STAT | (Tweet)

Recent Funding